Graham BS - Search Results

1

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.

Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE Jr, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, Higgins D, Hirve S, Klugman KP, Kragten-Tabatabaie L, Lemey P, Libster R, Löwensteyn Y, Mejias A, Munoz FM, Munywoki PK, Mwananyanda L, Nair H, Nunes MC, Ramilo O, Richmond P, Ruckwardt TJ, Sande C, Srikantiah P, Thacker N, Waldstein KA, Weinberger D, Wildenbeest J, Wiseman D, Zar HJ, Zambon M, Bont L. Mazur NI, et al. Among authors: graham bs. Lancet Infect Dis. 2023 Jan;23(1):e2-e21. doi: 10.1016/S1473-3099(22)00291-2. Epub 2022 Aug 8. Lancet Infect Dis. 2023. PMID: 35952703 Free PMC article. Review.

2

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.

Corey L, McElrath MJ, Weinhold K, Matthews T, Stablein D, Graham B, Keefer M, Schwartz D, Gorse G. Corey L, et al. J Infect Dis. 1998 Feb;177(2):301-9. doi: 10.1086/514202. J Infect Dis. 1998. PMID: 9466515 Clinical Trial.

3

Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.

Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, Robinson F, Coleman-Dockery S, Graham BS. Wright PF, et al. Among authors: graham bs. J Infect Dis. 2002 Apr 15;185(8):1011-8. doi: 10.1086/339822. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 11930309 Clinical Trial.

4

Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.

Rutigliano JA, Rock MT, Johnson AK, Crowe JE Jr, Graham BS. Rutigliano JA, et al. Among authors: graham bs. Virology. 2005 Jul 5;337(2):335-43. doi: 10.1016/j.virol.2005.04.032. Virology. 2005. PMID: 15916793 Free article.

5

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS; Vaccine Research Center 006 Study Team. Catanzaro AT, et al. Among authors: graham bs. J Infect Dis. 2006 Dec 15;194(12):1638-49. doi: 10.1086/509258. Epub 2006 Nov 8. J Infect Dis. 2006. PMID: 17109335 Free PMC article. Clinical Trial.

6

Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection.

Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS. Rutigliano JA, et al. Among authors: graham bs. Virology. 2007 Jun 5;362(2):314-9. doi: 10.1016/j.virol.2006.12.023. Epub 2007 Feb 2. Virology. 2007. PMID: 17275872 Free PMC article.

7

A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

Martin JE, Pierson TC, Hubka S, Rucker S, Gordon IJ, Enama ME, Andrews CA, Xu Q, Davis BS, Nason M, Fay M, Koup RA, Roederer M, Bailer RT, Gomez PL, Mascola JR, Chang GJ, Nabel GJ, Graham BS. Martin JE, et al. Among authors: graham bs. J Infect Dis. 2007 Dec 15;196(12):1732-40. doi: 10.1086/523650. J Infect Dis. 2007. PMID: 18190252 Free PMC article. Clinical Trial.

8

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.

Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS. Ruckwardt TJ, et al. Among authors: graham bs. J Virol. 2009 Apr;83(7):3019-28. doi: 10.1128/JVI.00036-09. Epub 2009 Jan 19. J Virol. 2009. PMID: 19153229 Free PMC article.

9

Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS. Liu J, et al. Among authors: graham bs. J Virol. 2009 May;83(10):4934-41. doi: 10.1128/JVI.02140-08. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264776 Free PMC article.

10

Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Liu J, Ruckwardt TJ, Chen M, Nicewonger JD, Johnson TR, Graham BS. Liu J, et al. Among authors: graham bs. J Virol. 2010 Oct;84(20):10501-9. doi: 10.1128/JVI.00963-10. Epub 2010 Aug 4. J Virol. 2010. PMID: 20686045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page